Analysis Outlook Therapeutics: A 479% Surge Sets the Stage for a July of High Stakes
Outlook Therapeutics has stormed back from the brink. The stock closed Friday at $1.58, marking a roughly 479% gain over the past 30 days and a near-tenfold move from its...